ADAM10 Missense Mutations Potentiate β-Amyloid Accumulation by Impairing Prodomain Chaperone Function

Suh, Jaehong, Choi, Se Hoon, Romano, Donna M., Gannon, Moira A., Lesinski, Andrea N., Kim, Doo Yeon, Tanzi, Rudolph E.·2013·Neuron

Cited by (220)

Items 101–200 of 220

  1. Dendrobium alkaloids decrease Aβ by regulating α- and β-secretases in hippocampal neurons of SD rats
    Juan Huang, Nanqu Huang, Minghui Zhang, Jing Nie, Yun‐Yan Xu, Qin Wu, Jingshan Shi · 2019 · PeerJ
  2. Upregulation of Alzheimer’s Disease Amyloid-β Protein Precursor in Astrocytes Both in vitro and in vivo
    Yingxia Liang, Frank Raven, Joseph F. Ward, Sherri Y. Zhen, Siyi Zhang, Haoqi Sun, Sean Miller, Se Hoon Choi, Rudolph E. Tanzi, Can Martin Zhang · 2020 · Journal of Alzheimer s Disease
  3. Non-Amyloid Approaches to Disease Modification for Alzheimer's Disease: An EU/US CTAD Task Force Report
    Serge G. Gauthier, Paul S. S. Aisen, Jeffrey L. Cummings, Michael J. Detke, Frank M. Longo, Rema Raman, Marwan Noel Sabbagh, Lon S. Schneider, Rudolph E. Tanzi, Pierre N. Tariot et al. · 2020 · The Journal of Prevention of Alzheimer s Disease
  4. Methyl-CpG Binding Protein 2 in Alzheimer Dementia
    Baeksun Kim, Yunjung Choi, Hye-Sun Kim, Heh‐In Im · 2019 · International Neurourology Journal
  5. α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer’s disease
    Pablo Agüero, María José Sainz, María‐Salud García‐Ayllón, Javier Sáez‐Valero, Raquel Téllez, Rosa Guerrero, Julián Pérez‐Pérez, Adriano Jiménez‐Escrig, Estrella Gómez‐Tortosa · 2020 · Alzheimer s Research & Therapy
  6. Nonamyloidogenic processing of amyloid beta precursor protein is associated with retinal function improvement in aging male APPswe/PS1ΔE9 mice
    Sandrine Joly, Simon Lamoureux, Vincent Pernet · 2017 · Neurobiology of Aging
  7. The regulatory mechanism and therapeutic potential of transcription factor EB in neurodegenerative diseases
    Fengjuan Jiao, Bojie Zhou, Lingyan Meng · 2022 · CNS Neuroscience & Therapeutics
  8. Dysregulated APP expression and α-secretase processing of APP is involved in manganese-induced cognitive impairment
    Yiping Yang, Jie Zhang, Xiaobo Yang, Zhiying Li, Jian Wang, Cailing Lu, Aruo Nan, Yunfeng Zou · 2021 · Ecotoxicology and Environmental Safety
  9. Tuning of Glutamate, But Not GABA, Release by an Intrasynaptic Vesicle APP Domain Whose Function Can Be Modulated by β- or α-Secretase Cleavage
    Wen Yao, Marc D. Tambini, Xinran Liu, Luciano D'adamio · 2019 · Journal of Neuroscience
  10. Low‐variance RNAs identify Parkinson's disease molecular signature in blood
    Maria D. Chikina, Christophe Gerald, Xianting Li, Yongchao Ge, Hanna Pinças, Venugopalan D. Nair, Aaron K. Wong, Arjun Krishnan, Olga G. Troyanskaya, Deborah Raymond et al. · 2015 · Movement Disorders
  11. Dysregulated expression of miR-140 and miR-122 compromised microglial chemotaxis and led to reduced restriction of AD pathology
    Chao Song, Shufang Li, Yingren Mai, Linpeng Li, Guoku Dai, Yuan Zhou, Xiaosheng Liang, Olivia Meilan Zou, Ya Wang, Libing Zhou et al. · 2024 · Journal of Neuroinflammation
  12. Epigenetic profiling of Italian patients identified methylation sites associated with hereditary transthyretin amyloidosis
    Antonella De Lillo, Gita A. Pathak, Flavio De Angelis, Marco Di Girolamo, Marco Luigetti, Mario Sabatelli, Federico Perfetto, Sabrina Frusconi, Dario Manfellotto, Maria Fuciarelli et al. · 2020 · Clinical Epigenetics
  13. Nmnat2 attenuates amyloidogenesis and up-regulates ADAM10 in AMPK activity-dependent manner
    Xiangshu Cheng, Fang-Xiao Shi, Kun-Peng Zhao, Wang Lin, Xiao-Ying Li, Jun Zhang, Yao-Yao Bu, Rui Zhu, Xiao-Hong Li, Dong-Xiao Duan et al. · 2021 · Aging
  14. The role of ADAM10 in astrocytes: Implications for Alzheimer’s disease
    Richard J. Elsworthy, Eric James Hill, Connor Dunleavy, Sarah Aldred · 2022 · Frontiers in Aging Neuroscience
  15. Mesenchymal stem cell-derived extracellular vesicles: A novel promising neuroprotective agent for Alzheimer's disease.
    Jun Chang, Zi-Hang Feng, Yu-Jiao Li, Honglin Lv, Shu-Zhen Liu, Yong-Yin Luo, Nan Hao, Lan Zhao, Jian-Wei Liu · 2024 · Biochemical Pharmacology
  16. Sulfuretin exerts diversified functions in the processing of amyloid precursor protein
    Jian Chen, Biao Luo, Bi‐Rou Zhong, Kunyi Li, Qi‐Xin Wen, Song Li, Xiaojiao Xiang, Gui‐Feng Zhou, Li‐Tian Hu, Xiaojuan Deng et al. · 2020 · Genes & Diseases
  17. APPsα rescues CDK5 and GSK3β dysregulation and restores normal spine density in Tau transgenic mice
    Danny Baltissen, Charlotte S. Bold, Lena Rehra, Marija Banićević, Justus Fricke, Jennifer Just, Susann Ludewig, Christian J. Buchholz, Martin Körte, Ulrike Müller · 2023 · Frontiers in Cellular Neuroscience
  18. Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms
    Barbara Vuić, Tina Milos, Lucija Tudor, Matea Nikolac Perković, Marcela Konjevod, Gordana Nedić Erjavec, Vladimir Farkaš, Suzana Uzun, Ninoslav Mimica, Dubravka Švob Štrac · 2023 · Genes
  19. Extracellular-Signal-Regulated Kinase Inhibition Switches APP Processing from β- to α-Secretase under Oxidative Stress: Modulation of ADAM10 by SIRT1/NF-κB Signaling
    Swaroop Thonda, Srinivas N. Puttapaka, Swathi V. Kona, Shasi V. Kalivendi · 2021 · ACS Chemical Neuroscience
  20. Proteomic analysis of silenced cathepsin B expression suggests non-proteolytic cathepsin B functionality
    Florian Christoph Sigloch, Julia Daniela Knopf, Juliane Weißer, Alejandro Gomez‐Auli, Martin Lothar Biniossek, Agnese Petrera, Oliver Schilling · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  21. Molecular systems evaluation of oligomerogenic APPE693Q and fibrillogenic APPKM670/671NL/PSEN1Δexon9 mouse models identifies shared features with human Alzheimer’s brain molecular pathology
    Ben Readhead, Jean‐Vianney Haure‐Mirande, Bin Zhang, Vahram H. Haroutunian, Sam Gandy, E E Schadt, Joel T. Dudley, M E Ehrlich · 2015 · Molecular Psychiatry
  22. Towards a Unitary Hypothesis of Alzheimer’s Disease Pathogenesis
    E. Area-Gómez, E. Schon · 2024 · Journal of Alzheimer's Disease
  23. Amyloid β and Amyloid Precursor Protein Synergistically Suppress Large-Conductance Calcium-Activated Potassium Channel in Cortical Neurons
    Kenji Yamamoto, Ryo Yamamoto, Nobuo Kato · 2021 · Frontiers in Aging Neuroscience
  24. Possible involvement of endoplasmic reticulum stress in the pathogenesis of Alzheimer’s disease
    Toru Hosoi, Jun Nomura, K. Ozawa, A. Nishi, Y. Nomura · 2015 · Endoplasmic Reticulum Stress in Diseases
  25. ADAM10 suppresses demyelination and reduces seizure susceptibility in cuprizone-induced demyelination model
    Xinjian Zhu, Yuanyuan Yao, Jiurong Yang, Canyu Zhang, Xinyan Li, Aifeng Zhang, Xiufang Liu, Chenchen Zhang, Guangming Gan · 2021 · Free Radical Biology and Medicine
  26. The Therapeutic Potential of Flavonols in Alzheimer's Disease: Inhibiting Amyloid‐β, Oxidative Stress, and Neuroinflammation
    Mohammad Yasin Zamanian, Lusine Khachatryan, Mahzad Heidari, Razieh Darabi, Maryam Golmohammadi, Raed Fanoukh Aboqader Al-Aouadi, Esra Küpeli Akkol · 2025 · BioFactors
  27. Shifting the balance: soluble ADAM10 as a potential treatment for Alzheimer's disease
    Ayelet Sarah Hershkovits, Sivan Gelley, Rawad Hanna, Oded Kleifeld, Avidor Shulman, Ayelet Fishman · 2023 · Frontiers in Aging Neuroscience
  28. Upregulation of sFRP1 Is More Profound in Female than Male 5xFAD Mice and Positively Associated with Amyloid Pathology
    Jesse R. Macyczko, Na Wang, Wenyan Lü, Suren Jeevaratnam, Francis Shue, Yuka A. Martens, Chia‐Chen Liu, Takahisa Kanekiyo, Guojun Bu, Yonghe Li · 2023 · Journal of Alzheimer s Disease
  29. Common and Rare Genetic Variants Associated With Alzheimer's Disease
    Hany E. S. Marei, Asmaa A. Al Thani, Jaana Suhonen, Mohamed Ezzat El Zowalaty, Mohammad A. Al-Banna, Carlo Cenciarelli, Tengfei Wang, Thomas Caceci · 2015 · Journal of Cellular Physiology
  30. SHMT2 Mediates Small‐Molecule‐Induced Alleviation of Alzheimer Pathology Via the 5′UTR‐dependent ADAM10 Translation Initiation
    Li Song, Qiuling Pan, Gui‐Feng Zhou, Shengwei Liu, Binglin Zhu, Peijia Lin, Xiaotong Hu, Jing‐Si Zha, Yan Long, Biao Luo et al. · 2024 · Advanced Science
  31. Mechanistic Approach to Immunity and Immunotherapy of Alzheimer’s Disease: A Review
    Md. Rubiath Islam, Md. Afser Rabbi, Tanbir Hossain, Sadia Sultana, Shihab Uddin · 2024 · ACS Chemical Neuroscience
  32. sAPPβ and sAPPα increase structural complexity and E/I input ratio in primary hippocampal neurons and alter Ca2+ homeostasis and CREB1-signaling
    Raphael Hesse, Bjoern von Einem, Franziska Wagner, Patricia Bott, Daniel Schwanzar, Rosemary J. Jackson, Karl J. Föhr, Ludwig M. Lausser, Katja S. Kroker, Christian Proepper et al. · 2018 · Experimental Neurology
  33. Type 2 diabetes-associated single nucleotide polymorphism in Sorcs1 gene results in alternative processing of the Sorcs1 protein in INS1 β-cells
    Belinda Yau, Zachary Blood, Yousun An, Zhiduan Su, Melkam Alamerew Kebede · 2019 · Scientific Reports
  34. Genetic Editing and Pharmacogenetics in Current And Future Therapy Of Neurocognitive Disorders
    Michał Prendecki, Marta Kowalska, Ewa Totoń, Wojciech P. Kozubski · 2020 · Current Alzheimer Research
  35. Succinylation Links Metabolic Reductions to Amyloid and Tau Pathology
    Yun Yang, Vı́ctor Tapias, Diana M. Acosta, Hui Xu, Huan‐Lian Chen, Ruchika P. Bhawal, Elizabeth Anderson, Elena Ivanova, Hening Lin, Botir T. Sagdullaev et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  36. Haploinsufficiency and Alzheimer’s Disease: The Possible Pathogenic and Protective Genetic Factors
    Eva Bagyinszky, Seong Soo A. An · 2024 · International Journal of Molecular Sciences
  37. Harnessing neurogenesis in the adult brain—A role in type 2 diabetes mellitus and Alzheimer’s disease
    Orly Lazarov, R. Minshall, M. Bonini · 2020 · International review of neurobiology
  38. The Genetic Basis of Alzheimer's Disease
    Basavaraj V. Hooli, Rudolph E. Tanzi · 2016 · Elsevier eBooks
  39. Alzheimer’s Disease and Dementia
    Patrick Alfryn Lewis, Jennifer E. Spillane · 2018 · Elsevier eBooks
  40. Targeting amyloid precursor protein shuttling and processing - long before amyloid beta formation
    Sage Arbor · 2017 · Neural Regeneration Research
  41. Massachusetts Alzheimer's Disease Research Center: Progress and challenges
    Bradley T. Hyman, John H. Growdon, Mark W. Albers, Randy L. Buckner, Jasmeer P. Chhatwal, Teresa Gómez‐Isla, Christian Haass, Eloïse Hudry, Clifford R. Jack, Keith A. Johnson et al. · 2015 · Alzheimer s & Dementia
  42. Brain delivery of a neurotrophic peptide derived from secreted amyloid precursor protein APPsα as a therapeutic strategy for Alzheimer's disease
    Lena Rehra, Susanne Erdinger, Lelia Wagner, Danny Baltissen, Jennifer Just, Leo König, Eric Mühlberg, Tom Eisenzapf, Lara Kilian, Marija Banićević et al. · 2025 · Journal of Controlled Release
  43. Phosphodiesterase 4D Gene Modifies the Functional Network of Patients With Mild Cognitive Impairment and Alzheimer’s Disease
    Jie Xiang, Xin Wang, Yuan Gao, Ting Li, Rui Cao, Ting Yan, Yunxiao Ma, Yan Niu, Jiayue Xue, Bin Wang · 2020 · Frontiers in Genetics
  44. Endoglycan (PODXL2) is proteolytically processed by ADAM10 (a disintegrin and metalloprotease 10) and controls neurite branching in primary neurons
    Hung‐En Hsia, Johanna Tüshaus, Xiao Ming Feng, Laura I. Hofmann, Benedikt Wefers, Denise K. Marciano, Wolfgang Wurst, Stefan F. Lichtenthaler · 2021 · The FASEB Journal
  45. ADAM10 Gene Variants in AD Patients and Their Relationship to CSF Protein Levels
    Pablo Agüero, Julián Pérez‐Pérez, Lucía Cremades‐Jimeno, María‐Salud García‐Ayllón, Adriana Gea‐González, María José Sainz, Ignacio Mahíllo, Raquel Téllez, Blanca Cárdaba, Javier Sáez‐Valero et al. · 2023 · International Journal of Molecular Sciences
  46. Autophagy-Dependent Increased ADAM10 Mature Protein Induced by TFEB Overexpression Is Mediated Through PPARα
    Hongjie Wang, Mohan Kumar Muthu Karuppan, Madhavan Nair, Madepalli Krishnappa Lakshmana · 2021 · Molecular Neurobiology
  47. Neuroprotective role of herbal alternatives in circumventing Alzheimer’s disease through multi-targeting approach - a review
    Sunil K. Ravi, Balenahalli Narasingappa Ramesh, Shilpa Kj, Jagadeesha Poyya, Jyothsna Karanth, Narayanappa Govinda Raju, Chandrashekhar G. Joshi · 2022 · Egyptian Journal of Basic and Applied Sciences
  48. Escape from X-chromosome inactivation and sex differences in Alzheimer’s disease
    Qing-Hua Song, Ke-Xuan Zhao, Shuai Huang, Tong Chen, Ling He · 2023 · Reviews in the Neurosciences
  49. Unraveling the dual role of ADAM10: Bridging the gap between cancer and Alzheimer’s disease
    Vanessa Alexandre-Silva, Márcia R. Cominetti · 2024 · Mechanisms of Ageing and Development
  50. Exploring Heparan Sulfate Proteoglycans as Mediators of Human Mesenchymal Stem Cell Neurogenesis
    Sofia I. Petersen, Rachel K. Okolicsanyi, Larisa Margaret Haupt · 2024 · Cellular and Molecular Neurobiology
  51. Fluorescent Analogue of Batimastat Enables Imaging of α-Secretase in Living Cells
    Geoffray Leriche, Allen C. Chen, Sumin Kim, Dennis J. Selkoe, Jerry Yang · 2015 · ACS Chemical Neuroscience
  52. The Genetic Basis of Alzheimer’s Disease
    Basavaraj V. Hooli, Rudolph E. Tanzi · 2016 · Elsevier eBooks
  53. Critical analysis of the use of β-site amyloid precursor protein-cleaving enzyme 1 inhibitors in the treatment of Alzheimer's disease
    Genevieve M. Evin, Adel Barakat · 2014 · Degenerative Neurological and Neuromuscular Disease
  54. Monocular denervation of visual nuclei modulates APP processing and sAPPα production: A possible role on neural plasticity
    Juliana Ferreira Vasques, Pedro Vinícius Bastos Heringer, Renata Guedes de Jesus Gonçalves, Paula Campello‐Costa, Claudio Alberto Serfaty, Adriana da Cunha Faria‐Melibeu · 2017 · International Journal of Developmental Neuroscience
  55. The Role of Genetics in Alzheimer's Disease and Parkinson's Disease
    Tenielle Porter, Aleksandra Gozt, Francis L. Mastaglia, Simon Matthew Laws · 2019 · Wiley eBooks
  56. Different Expression Patterns of Amyloid-β Protein Precursor Secretases in Human and Mouse Hippocampal Neurons: A Potential Contribution to Species Differences in Neuronal Susceptibility to Amyloid-β Pathogenesis
    Zhiqiang Xu, Huang Huang, Yali Chen, Yun-Ying Gao, Jun Xu, Charles Marshall, Zhiyou Cai, Ming Xiao · 2016 · Journal of Alzheimer s Disease
  57. Targeting ADAM10 in Renal Diseases
    Jie-Na Wang, Xiao-Jing Cao · 2022 · Current Molecular Medicine
  58. Ectodomain shedding of EGFR ligands serves as an activation readout for TRP channels
    Manae Tatsumi, Takayuki Kishi, Satoru Ishida, Hiroki Kawana, Akiharu Uwamizu, Yuki Ono, Kouki Kawakami, Junken Aoki, Asuka Inoue · 2023 · PLoS ONE
  59. The role of immunity and neuroinflammation in genetic predisposition and pathogenesis of Alzheimer’s disease
    Seoyoung Yoon, Yong‐Ku Kim · 2015 · Global Medical Genetics
  60. Mapping Breakpoints of Complex Chromosome Rearrangements Involving a Partial Trisomy 15q23.1-q26.2 Revealed by Next Generation Sequencing and Conventional Techniques
    Qiong Pan, Hao Hu, Liangrong Han, Xin Jing, Hailiang Liu, Chuanchun Yang, Fengting Zhang, Yue Hu, Hongni Yue, Ying Ning · 2016 · PLoS ONE
  61. Novel social stimulation ameliorates memory deficit in Alzheimer's disease model through activating α-secretase
    Qiaoyun Ren, Susu Wang, Junru Li, Kun Cao, Mei Zhuang, Miao Wu, Junhua Geng, Zhengping Jia, Wei Xie, An Liu · 2024 · Journal of Neuroscience
  62. Melatoninergic Pathways in Alzheimer's Disease
    G. Maes · 2015 · BENTHAM SCIENCE PUBLISHERS eBooks
  63. Alzheimer’s Disease: Causes, Mechanisms, and Steps Toward Prevention
    Se Hoon Choi, Rudolph E. Tanzi · 2020 · Oxford University Press eBooks
  64. QTC-4-MeOBnE Ameliorated Depressive-Like Behavior and Memory Impairment in 3xTg Mice
    Mariana G. Fronza, Manoela Sacramento, Diego A.C. Alves, Domenico Praticò, Lucielli Savegnago · 2022 · Molecular Neurobiology
  65. APP as an innate injury-response molecule
    Zachary T. Olmsted, Michael V. Sofroniew · 2026 · Neurobiology of Disease
  66. Genetic and Epigenetic Architecture of Alzheimer’s Dementia
    Laura Cervera‐Carles, Jordi Clarimón · 2016 · Current Genetic Medicine Reports
  67. Computational analysis and molecular dynamics simulation of high-risk single nucleotide polymorphisms of the ADAM10 gene
    Jannatun Nayem Namme, Hasan Mahmud Reza, Asim Kumar Bepari · 2023 · Journal of Biomolecular Structure and Dynamics
  68. Deciphering the Role of Peroxisome Proliferator-activated Receptor α and Phosphodiesterase Type 5 Targets in Alzheimer's Disease
    Parnika M. Sose, Pravin Popatrao Kale, Gaurav Doshi · 2023 · CNS & Neurological Disorders - Drug Targets
  69. Preclinical models of Alzheimer’s disease for identification and preclinical validation of therapeutic targets: from fine-tuning strategies for validated targets to new venues for therapy
    Bruno Vasconcelos, Matthew Bird, Ilie‐Cosmin Stancu, Dick Terwel, Ilse Dewachter · 2017 · Elsevier eBooks
  70. Genome sequencing for early-onset dementia: high diagnostic yield and frequent observation of multiple contributory alleles
    J. Nicholas Cochran, Emily McKinley, Meagan Cochran, Michelle D. Amaral, Bryan A. Moyers, Brittany N. Lasseigne, David E. Gray, James M.J. Lawlor, Jeremy W. Prokop, Ethan G. Geier et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  71. Structural Basis for Selective Proteolysis of ADAM10 Substrates at Membrane-Proximal Sites
    Colin H. Lipper, Emily D. Egan, Khal-Hentz Gabriel, Stephen C. Blacklow · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  72. Role of redox-sensitive catalytic interaction with ADAM10 in mutant-selective extracellular shedding of prion protein
    Yejin Shin, Kang-Sug Jo, Minseok Shin, Duri Lee, Hyejin Yeo, Youngsup Song, Sang‐Wook Kang · 2022 · Redox Biology
  73. An overview of the role of MMP-8 and ADAM-33 in bronchial asthma
    Kahan Celik, Tanya Tacheva, Dimo Dimov, Tatyana Ivanova Vlaykova · 2024 · Biotechnology & Biotechnological Equipment
  74. From genetic roots to recent advancements in gene therapy targeting amyloid beta in Alzheimer’s disease
    Pinar Peyvand, Pantea Allami, Nima Rezaei · 2025 · Reviews in the Neurosciences
  75. Biomarkers for Alzheimer's Disease and Potential Future Directions
    Usman Zafar Paracha, Ishtiaq Qadri, Khezar Hayat, Talib Hussain · 2013
  76. Risk Factors for Alzheimer’s Disease
    Dongming Cai, Farida El Gaamouch · 2016 · InTech eBooks
  77. Genetics of Alzheimer's disease: an update
    M. Tang, C. Reitz · 2017 · Future Neurology
  78. Basics of amyloid β-protein in Alzheimer’s disease
    Azusa Sugimoto, Kenjiro Ono · 2022 · Elsevier eBooks
  79. ADAM10: α-secretase in Alzheimer’s disease and regulator of neurobiology
    Paul Säftig, Johannes Prox · 2014 · e-Neuroforum
  80. PROGRAMA PARA EL ENTRENAMIENTO DE LA ACTIVIDAD COGNITIVA EN EL ADULTO MAYOR
    Osvaldo León Bravo, Dotmaro Valdés Camacho, Pedro Antonio Valdes-Sosa, Dionisio Zaldívar Pérez · 2018 · Impetus
  81. Paul Greengard, Ph.D. (1925‐2019)
    Sam Gandy, Toshiharu Suzuki · 2019 · Alzheimer s & Dementia
  82. Glutamine 666 renders murine ADAM10 an inefficient S. aureus α-toxin receptor
    Gisela von Hoven, Martina Meyenburg, Claudia Neukirch, Daniel Siedenschnur, Matthias Husmann · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  83. α-Secretase processing of the Alzheimer amyloid-β precursor protein and its homolog APLP2
    Kristin T. Jacobsen · 2013 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  84. Shedding the Epilepsy Comorbidity in Alzheimer's Disease
    Elizabeth M. Powell · 2014 · Epiliepsy currents/Epilepsy currents
  85. Identification of ADAM10 5`UTR binding proteins - The RNA-binding protein Unr is involved in ADAM10 mRNA stability
    Christian Haass · 2014
  86. Effects of DHA and EGCG on the alpha-secretase mediated processing of APP
    Hawmid Azizi · 2015 · The Atrium (University of Guelph)
  87. Loss of Ataxin-1 Elevates BACE1 Expression and Impairs Axonal Targeting in the Cerebrum
    Jaehong Suh, Donna Romano, Scott P. Herrick, Basavaraj V. Hooli, Mary K. Oram, Kristina Mullin, Wilma Wasco, Jeremy Dan Schmahmann, Mark W. Albers, Rudolph E. Tanzi · 2018 · SSRN Electronic Journal
  88. Implications of alpha- and beta-secretase expression and function in Alzheimer's disease
    Sven Reinhardt, K. Endres · 2020 · Elsevier eBooks
  89. The effect of genes and diet on Alzheimer's disease-related molecular mechanisms : Influence of ubiquilin-1 and dietary lipids
    Mari Takalo · 2015 · UEF eRepo (University of Eastern Finland)
  90. Peer Review #1 of "Dendrobium alkaloids decrease Aβ by regulating α- and β-secretases in hippocampal neurons of SD rats (v0.2)"
    2019 · PeerJ
  91. Peer Review #2 of "Dendrobium alkaloids decrease Aβ by regulating α- and β-secretases in hippocampal neurons of SD rats (v0.1)"
    2019 · PeerJ
  92. Peer Review #1 of "Dendrobium alkaloids decrease Aβ by regulating α- and β-secretases in hippocampal neurons of SD rats (v0.1)"
    2019 · PeerJ
  93. The Role and Therapeutic Potential of α-secretase in Alzheimer’s Disease
    Vandana Peddapalli, Patricija van Oosten‐Hawle · 2023 · Journal of Student Research
  94. Is it possible to maintain a plaque-free healthy brain by treadmill?
    Swarupa Pahan, Kalipada Pahan · 2024 · Neural Regeneration Research
  95. A Valuable Target for Therapy: The Metalloproteinase ADAM10
    Siddhant Tripathi, Yashika Sharma, Dileep Kumar · 2025 · Current Protein and Peptide Science
  96. Mechanism of synergistic enhancement of α-secretase (ADAM10) activity by EGCG and FA
    Yvning Guan, Wen Xu, Hongqi Ai · 2025 · ChemPhysMater
  97. Revealing the nervous system requirements of Alzheimer’s disease risk genes in Drosophila
    Jennifer Deger, Shabab B. Hannan, Mingxue Gu, Colleen E Strohlein, Lindsey D. Goodman, Sasidhar Pasupuleti, Zahid Shaik, Liwen Ma, Yarong Li, Jiayang Li et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  98. Additional file 3 of Epigenetic profiling of Italian patients identified methylation sites associated with hereditary transthyretin amyloidosis
    Antonella De Lillo, Pathak, Gita A., De Angelis, Flavio, Di Girolamo, Marco, Marco Luigetti, Mario Sabatelli, Federico Perfetto, Sabrina Frusconi, Dario Manfellotto, Maria Fuciarelli et al. · 2020 · Figshare
  99. Additional file 5 of Dysregulated expression of miR-140 and miR-122 compromised microglial chemotaxis and led to reduced restriction of AD pathology
    Chao Song, Li, Shufang, Mai, Yingren, Li, Linpeng, Guoku Dai, Zhou, Yuan, Xiaosheng Liang, Olivia Meilan Zou, Wang, Ya, Libing Zhou et al. · 2024 · Figshare
  100. Additional file 3 of Dysregulated expression of miR-140 and miR-122 compromised microglial chemotaxis and led to reduced restriction of AD pathology
    Chao Song, Li, Shufang, Mai, Yingren, Li, Linpeng, Guoku Dai, Zhou, Yuan, Xiaosheng Liang, Olivia Meilan Zou, Wang, Ya, Libing Zhou et al. · 2024 · Figshare